Prognostic Trajectories of Functional Independence in Adults With Multimorbidity

Abstract

Functional independence is a pivotal determinant of quality of life and overall prognosis in adults with multimorbidity. This review synthesizes recent evidence on the prognostic trajectories of functional independence in this population, highlighting epidemiological trends, underlying mechanisms, risk factors, clinical features, and current diagnostic and therapeutic strategies. Special attention is given to emerging therapies and guideline-based recommendations, aiming to equip clinicians with actionable insights for optimizing long-term outcomes in this growing and complex patient group.

Introduction

Multimorbidity, defined as the coexistence of two or more chronic medical conditions in an individual, poses significant challenges to healthcare systems globally. Its prevalence increases with age and is associated with decreased functional independence, higher healthcare utilization, and poorer clinical outcomes. Understanding the prognostic trajectories of functional independence in adults with multimorbidity is crucial for informing clinical management, resource allocation, and the development of targeted interventions. This article critically reviews the current literature, emphasizing the interplay of biological, psychosocial, and healthcare system factors that shape these trajectories.

Epidemiology / Disease Burden

Globally, the prevalence of multimorbidity among adults ranges from 25% to 60%, with higher rates observed in older populations and those of lower socioeconomic status. Loss of functional independence—defined as the inability to perform activities of daily living (ADLs) without assistance—is a common and devastating consequence. Epidemiological studies, such as the Health and Retirement Study and the Global Burden of Disease project, have consistently shown that individuals with multimorbidity are at a two- to four-fold increased risk of functional decline compared to those with single chronic conditions. The societal burden is further amplified by increased hospitalization rates, long-term care admissions, and informal caregiver strain.

Pathophysiology

The pathophysiological underpinnings of functional decline in multimorbid adults are multifactorial. Shared pathways include chronic systemic inflammation, neurohormonal dysregulation, vascular compromise, and sarcopenia. Cumulative disease burden leads to a decrease in physiological reserve and resilience, rendering individuals more susceptible to functional decompensation after stressors such as hospitalization or acute illness. Furthermore, the interaction between physical and cognitive impairments—often mediated by vascular disease, metabolic dysfunction, and neurodegeneration—exacerbates the risk of loss of independence. Mechanism-based research underscores the importance of addressing both organ-specific and systemic contributors to functional decline.

Risk Factors

Key risk factors for accelerated functional decline in adults with multimorbidity include advanced age, polypharmacy, cognitive impairment, depression, low socioeconomic status, and physical inactivity. The number and severity of comorbid conditions, particularly when involving cardiovascular, musculoskeletal, or neurological systems, are strongly predictive of poorer functional trajectories. Sociodemographic factors, including social isolation and lack of access to healthcare resources, further compound vulnerability. Recent studies also highlight the prognostic value of frailty indices and inflammatory biomarkers in risk stratification.

Clinical Features

Clinically, adults with multimorbidity at risk for functional decline may present with progressive difficulties in ADLs, mobility limitations, frequent falls, and recurrent hospitalizations. Subtle early signs often include reduced gait speed, decreased grip strength, and fatigue. Comorbid cognitive impairment complicates assessment and management, as does the presence of overlapping symptoms such as pain, dyspnea, and urinary incontinence. Clinicians should maintain a high index of suspicion for declining independence, particularly in patients reporting new or worsening disability, changes in living circumstances, or increased caregiver requirements.

Diagnosis

Assessment of functional independence in multimorbid adults requires a multidimensional and interdisciplinary approach. Standardized tools such as the Katz Index of Independence in Activities of Daily Living, Lawton Instrumental Activities of Daily Living Scale, and the Short Physical Performance Battery are widely used for objective measurement. Comprehensive geriatric assessment (CGA) remains the gold standard, integrating physical, cognitive, psychological, and social domains. Serial assessments enable clinicians to monitor changes over time and to identify individuals at high risk for rapid decline, thereby informing care planning and interventions.

Treatment & Management

Management strategies for preserving functional independence in adults with multimorbidity are multifaceted and patient-centered. Optimization of medical therapy includes regular medication review to minimize polypharmacy and adverse drug events, aggressive management of chronic disease risk factors, and prompt treatment of acute exacerbations. Rehabilitation interventions—encompassing physical therapy, occupational therapy, and structured exercise programs—have demonstrated efficacy in improving mobility, strength, and ADL performance. Multidisciplinary care models, including case management and coordinated transitional care, are associated with reduced hospital readmissions and delayed institutionalization. Psychological support and social services are integral for addressing depression, caregiver burden, and socioeconomic barriers.

Recent Advances / Emerging Therapies

Recent advances in the management of functional independence among multimorbid adults include the integration of digital health technologies, such as tele-rehabilitation and remote monitoring, which facilitate ongoing functional assessment and intervention delivery. Novel pharmacological agents targeting sarcopenia and frailty are under investigation, with early data suggesting potential benefit in improving muscle mass and function. Individualized care plans using predictive analytics and artificial intelligence are being piloted to identify high-risk patients and tailor interventions. Furthermore, community-based programs promoting social engagement and physical activity have shown promise in sustaining functional independence outside traditional healthcare settings.

Guideline Recommendations

International and national guidelines, including those from the World Health Organization and the American Geriatrics Society, emphasize the importance of routine functional assessment and individualized care planning for adults with multimorbidity. Recommendations support the use of comprehensive geriatric assessment, multidisciplinary team-based management, and shared decision-making that incorporates patient goals and preferences. Guidelines advocate for deprescribing unnecessary medications, promoting physical activity, and addressing social determinants of health. Importantly, integration of palliative care principles is recommended for individuals with advanced multimorbidity and declining functional status, to optimize quality of life and align interventions with patient values.

Conclusion

The prognostic trajectories of functional independence in adults with multimorbidity are influenced by a complex interplay of biological, psychosocial, and healthcare factors. Early recognition, comprehensive assessment, and multidisciplinary intervention are critical for preserving independence and improving outcomes. Ongoing research and emerging therapies hold promise for more personalized and effective management strategies. Clinicians must remain vigilant in addressing the unique needs of this vulnerable population, guided by evidence-based recommendations and patient-centered care principles.